Khiron Life Sciences Corp. (KHRNF)
OTCMKTS · Delayed Price · Currency is USD
0.0000
+0.0000 (900.00%)
At close: Jul 18, 2025
Khiron Life Sciences Revenue
Khiron Life Sciences had revenue of 3.39M CAD in the quarter ending September 30, 2022, a decrease of -3.81%. This brings the company's revenue in the last twelve months to 16.14M, up 38.19% year-over-year. In the year 2021, Khiron Life Sciences had annual revenue of 12.80M with 59.60% growth.
Revenue (ttm)
16.14M CAD
Revenue Growth
+38.19%
P/S Ratio
0.00
Revenue / Employee
n/a
Employees
n/a
Market Cap
2.32K USD
Revenue Chart
* This company reports financials in CAD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2021 | 12.80M | 4.78M | 59.60% |
Dec 31, 2020 | 8.02M | -1.57M | -16.34% |
Dec 31, 2019 | 9.58M | 8.69M | 974.65% |
Dec 31, 2018 | 891.68K | - | - |
Dec 31, 2017 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo, Inc. | 1.73B |
Veradigm | 588.02M |
Tian'an Technology Group | 1.78M |
Elite Pharmaceuticals | 84.04M |
Glass House Brands | 215.62M |
Northwest Biotherapeutics | 1.47M |
American Oncology Network | 1.76B |
Silence Therapeutics | 27.70M |
Khiron Life Sciences News
- 11 days ago - Cannabis Stock Movers For July 14, 2025 - Benzinga
- 1 year ago - Khiron Life Sciences Announces Closing of the Sale of Its European Business - Newsfile Corp
- 1 year ago - Khiron Life Sciences Announces Update to the Proposed Sale of Its European Business - Newsfile Corp
- 2 years ago - Khiron Life Sciences Agrees to $500,000 Secured Deposit - Newsfile Corp
- 2 years ago - Medical First: Germany Strengthens Reimbursement of Medical Cannabis - Newsfile Corp
- 2 years ago - Khiron Completes First Phase of Business Optimization - Newsfile Corp
- 2 years ago - Khiron Life Sciences Announces Closing of Marketed Offering Including Full Exercise of Over-Allotment Option - Newsfile Corp
- 2 years ago - Khiron Closes Additional Loan with Investment-Grade Bank - Newsfile Corp